Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial.

Eiji OkiAkitaka MakiyamaYuji MiyamotoMasahiko KotakaHirofumi KawanakaKeisuke MiwaAkira KabashimaTomohiro NoguchiKotaro YugeTomomi KashiwadaKoji AndoMototsugu ShimokawaHiroshi SaekiYoshito AkagiHideo BabaYoshihiko MaeharaMasaki Mori

Published in: Cancer medicine (2020)

UMIN clinical trials registry (UMIN000025241).

Keyphrases

metastatic colorectal cancer
clinical trial
double blind
open label
middle aged
placebo controlled
phase ii
community dwelling
cross sectional
phase iii
randomized controlled trial